|
January 2021
Dear <<First Name>>,
Happy 2021.
Welcome to ACHSM Library Bulletin Special Issue on COVID-19 topics. This is the last issue in 2020. It's been a big year for all of us. COVID-19 has changed the world in ways we never imagined.
|
|
Outcomes for patients with COVID‐19: known knowns, known unknowns, and unknown unknowns
Mervyn Singer
Med J Aust 2021; 214 (1): 20-21
COVID-19 Australia epidemiology report: Four-week reporting period ending 3 January 2021
COVID-19 National Incident Room Surveillance Team
Communicable Diseases Intelligence 3 Jan 2021
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
Tom Shimabukuro, MD, MPH, MBA; Narayan Nair, MD
JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0600
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020
Weekly / January 15, 2021 / 70(2);46–51
All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020
Jeremy Samuel Faust, MD, MS; Harlan M. Krumholz, MD, SM; Chengan Du, PhD; et al.
JAMA. Published online December 16, 2020. doi:10.1001/jama.2020.24243
Covid 19: Hope is being eclipsed by deep frustration
BMJ 2021; 372 (Published 21 January 2021)
Covid-19: Doctors’ leaders call for revised PPE guidance to reflect new variants
BMJ 2021; 372 (Published 15 January 2021)
The COVID‐19 response: the health impacts of austerity measures
Shane A Kavanagh, Anthony D LaMontagne and Sharon Brennan‐Olsen
Med J Aust || doi: 10.5694/mja2.50925 Published online: 25 Jan 2021
Child protection in the time of COVID-19
AIHW 15 Jan 2021
COVID-19 rapid evidence summary: Sarilumab for COVID-19
NICE Evidence summary [ES34]Published date: 20 January 2021
COVID research updates: COVID vaccines might lose potency against new viral variants
Nature News 21 Jan 2021
CDNA National Guidance for Urban and Regional Aboriginal and Torres Strait Islander Communities for COVID-19
Communicable Diseases Network Australia (CDNA), 11 December 2020
Correlation of population mortality of COVID-19 and testing coverage: A comparison among 36 OECD countries.
Wei, C., Lee, C., Hsu, T., Hsu, W., Chan, C., Chen, S., & Chen, C.
Epidemiology and Infection, 2021,149, E1. doi:10.1017/S0950268820003076
Covid-19: What have we learnt about the new variant in the UK?
BMJ 2020; 371 (Published 23 December 2020)
Back to top
02 PREVENTION
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, M.D et al
NEJM December 30, 2020 DOI: 10.1056/NEJMoa2035389
PPE for your mind: a peer support initiative for health care workers
Tahnee L Bridson, Kym Jenkins, Kieran G Allen and Brett M McDermott
Med J Aust 2021; 214 (1): 8-11.e1
Ensuring equitable access to vaccines for refugees and migrants during the COVID-19 pandemic
Jozef Bartovic, Siddharta Sankar Datta, Santino Severoni & Veronika D'Anna
Bulletin of the World Health Organization 2021;99:3-3A
Converting the maybes: Crucial for a successful COVID-19 vaccination strategy.
Attwell K, Lake J, Sneddon J, Gerrans P, Blyth C, Lee J
PLoS ONE 2021, 16(1): e0245907.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, M.D. et al
N Engl J Med 2020; 383:2603-2615 December 31, 2020
Four million Australians to be vaccinated for COVID-19 by March
AAP | Published: 08-01-2021
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19
Aaron S. Kesselheim, Jonathan J. Darrow, Martin Kulldorff, Beatrice L. Brown, Mayookha Mitra-Majumdar, ChangWon C. Lee, Osman Moneer, and Jerry Avorn
Health Affairs 2021, 40(1): 25-32
Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities
Angela K. Shen, Richard Hughes IV, Erica DeWald, Sara Rosenbaum, Amy Pisani, and Walt Orenstein
Health Affairs 2021, 40(1): 62-69
The hierarchy of preventive measures to protect workers against the COVID-19 pandemic: A review.
Dehghani F, Omidi F, Yousefinejad S, Taheri E.
Work. 2020;67(4):771-777. doi: 10.3233/WOR-203330
The impact of COVID-19 pandemic on hand hygiene performance in hospitals
Lori D. Moore,Greg Robbins,Jeff Quinn,James W. Arbogast
American Journal of Infection Control, 2021, 49(1): 30-33
Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
Wei Wang, et al
BMJ 2020;371:m4704
Coronavirus: Covid-19 vaccine roll-out.
House of Commons Library 7 January 2021
The Covid-19 vaccine communication handbook
University of Bristol 7 January 2021
Covid-19 vaccination: What’s the evidence for extending the dosing interval?
BMJ 2021; 372 (Published 06 January 2021)
Second covid vaccine doses in doubt amid call for study into single jab.
Whipple T, Swinford S.
Times. 18 January 2021.
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey
Jeanette B.Ruiz et al
Vaccine online 9 January 2021
The Association between Early Country-level Testing Capacity and Later COVID-19 Mortality Outcomes
Sneha Kannoth, Sasikiran Kandula, Jeffrey Shaman
medRxiv and bioRxiv 20 Jan 2021
COVID-19 vaccines: where we stand and challenges ahead.
Forni, G., Mantovani, A., on behalf of the COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. et al.
Cell Death Differ (2021).
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
KATE M. BUBAR, et al
Science 21 Jan 2021: eabe6959
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
Weekly / January 1, 2021 / 69(5152);1653-1656
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, M.D, et al
New England Journal of Medicine December 30, 2020 DOI: 10.1056/NEJMoa2035389
mRNA-1273 vaccine (Moderna) against COVID-19 background document: draft prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines.
World Health Organization. 19 January 2021
Aide-memoire: infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities
World Health Organization, 15 January 2021.
Infection prevention and control guidance for long-term care facilities in the context of COVID-19: interim guidance
World Health Organization, 8 January 2021.
Bidirectional contact tracing could dramatically improve COVID-19 control.
Bradshaw, W.J., Alley, E.C., Huggins, J.H. et al.
Nat Commun 12, 232 (2021).
Back to top
03 DIAGNOSIS
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19
Beatriz Böger, Mariana M. Fachi, Raquel O. Vilhena, Alexandre F. Cobre, Fernanda S. Tonin, Roberto Pontarolo
American Journal of Infection Control, 2021, 49(1): 21-29
Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations
Sameer S. Kadri, MD; Jake Gundrum, MS; Sarah Warner, MPH; et al.
JAMA. 2020;324(24):2553-2554. doi:10.1001/jama.2020.20323
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis
Guillaume Butler-Laporte, MD; Alexander Lawandi, MD, MSc; Ian Schiller, MSc; et al
JAMA Intern Med. Published online January 15, 2021. doi:10.1001/jamainternmed.2020.8876
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis.
Mayara Lisboa Bastos, Sara Perlman-Arrow, Dick Menzies, et al.
Ann Intern Med.12 January 2021. doi:10.7326/M20-6569
Back to top
04 TREATMENTS
Covid-19: Arthritis drugs improve survival in intensive care patients, shows study
BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n61 (Published 08 January 2021)
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
BMJ 2021; 372 (Published 20 January 2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Robert L. Gottlieb, MD, PhD; Ajay Nirula, MD, PhD; Peter Chen, MD; et al
JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0202
Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review.
Hanna, R., Dalvi, S., Sălăgean, T., Pop, I. D., Bordea, I. R., & Benedicenti, S.
Journal of inflammation research, 2021,14, 13–56.
The Centre for Evidence-Based Medicine drug vignettes on Baricitini
Robin E Ferner, Jeffrey K Aronson
Centre for Evidence-Based Medicine 18 Jan 2021
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama, M.D.et al
N Engl J Med 2021; 384:20-30 DOI: 10.1056/NEJMoa2030340
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
Brenda T Pun, DNP et al
Lancet Respiratory Medicine January 08, 2021
Therapeutics and COVID-19: living guideline.
World Health Organization, 17 December 2020.
Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients
Imperial College London Press Release 23 December 2020
Covid-19: Arthritis drugs improve survival in intensive care patients, shows study
BMJ 2021; 372 (Published 08 January 2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Romina Libster, M.D, et al
New England Journal of Medicine January 6, 2021 DOI: 10.1056/NEJMoa2033700
Back to top
05 MANAGEMENT
Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
Aidan JC Burrell, Breanna Pellegrini, Farhad Salimi, et al
Med J Aust 2021; 214 (1): 23-30
COVID‐19 and residential aged care: priorities for optimising preparation and management of outbreaks
Georgia E Aitken, Alice L Holmes and Joseph E Ibrahim
Med J Aust 2021; 214 (1): 6-8.e1
COVID‐19 safety: aerosol‐generating procedures and cardiothoracic surgery and anaesthesia — Australian and New Zealand consensus statement
Joanne F Irons, Warren Pavey, Jayme S Bennetts, Emily Granger, Elli Tutungi and Aubrey Almeida
Med J Aust 2021; 214 (1): 40-44
Clinical practice guide for improving the management of adult Covid-19 patients in secondary care
Moulton C, Mann C, Batchelor A, Swart M, Chris S, Dyer P, et al
London: NHS England; 2020. p. 58.
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic.
de Val J, Sohal G, Sarwar A, Ahmed H, Singh I, Coleman JJ.
Eur J Hosp Pharm. 2021 Jan;28(1):10-15. doi: 10.1136/ejhpharm-2020-002364.
Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study
BMJ 2020;371:m4677
Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System
John P. Donnelly, PhD; Xiao Qing Wang, MPH; Theodore J. Iwashyna, MD, PhD; et al.
JAMA. Published online December 14, 2020. doi:10.1001/jama.2020.21465
Intensive Care Unit Strain and Mortality Risk Among Critically Ill Patients With COVID-19—There Is No “Me” in COVID
Lewis Rubinson, MD, PhD et al
JAMA Netw Open. 2021;4(1):e2035041. doi:10.1001/jamanetworkopen.2020.35041
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, MD, et al
Lancet 8 Jan 2021
Back to top
06 HEALTH SERVICES
A Guide to Promoting Health Care Workforce Well-Being During and After the COVID-19 Pandemic
Institute for Healthcare Improvement
Boston: Institute for Healthcare Improvement; 2020. p. 14.
Implementing a Pandemic Roster in a Specialty Emergency Department – Challenges & Benefits.
Au, B.W.Y., Tranquilino, R., Apswoude, G. and Crock, C. (2021),
Emergency Medicine Australasia. 18 January 2021
Built Environment Airborne Infection Control Strategies in Pandemic Alternative Care Sites.
Gordon D, Ward J, Yao CJ, Lee J.
HERD. 2020 Dec 14:1937586720979832. doi: 10.1177/1937586720979832. Online ahead of print.
Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers: interim guidance.
World Health Organization. , 14 January 2021
A conceptual framework for Emergency department design in a pandemic.
Nadarajan GD, Omar E, Abella BS, Hoe PS, Do Shin S, Ma MH, Ong MEH.
Scand J Trauma Resusc Emerg Med. 2020 Dec 17;28(1):118. doi: 10.1186/s13049-020-00809-7.
Assembly Line ICU: what the Long Shops taught us about managing surge capacity for COVID-19.
Oakley C, Pascoe C, Balthazor D, Bennett D, Gautam N, Isaac J, Isherwood P, Matthews T, Murphy N, Oelofse T, Patel J, Snelson C, Richardson C, Willson J, Wyton F, Veenith T, Whitehouse T; QEHB COVID-19 Response Team.
BMJ Open Qual. 2020 Dec;9(4):e001117. doi: 10.1136/bmjoq-2020-001117.
Critical Care Surge During the COVID-19 Pandemic: Implementation and Feedback From Frontline Providers.
Keene AB, Shiloh AL, Eisen L, Berger J, Karwa M, Fein D, Orsi D, Gong M.
J Intensive Care Med. 2021 Feb;36(2):233-240. doi: 10.1177/0885066620973175.
Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling framework.
Booton RD, MacGregor L, Vass L, Looker KJ, Hyams C, Bright PD, Harding I, Lazarus R, Hamilton F, Lawson D, Danon L, Pratt A, Wood R, Brooks-Pollock E, Turner KME.
BMJ Open. 2021 Jan 7;11(1):e041536. doi: 10.1136/bmjopen-2020-041536.
Risk of COVID-19-related bullying, harassment and stigma among healthcare workers: an analytical cross-sectional global study.
Dye TD, Alcantara L, Siddiqi S, Barbosu M, Sharma S, Panko T, Pressman E.
BMJ Open. 2020 Dec 30;10(12):e046620. doi: 10.1136/bmjopen-2020-046620.
Back to top
07 OTHER
Health research system resilience: lesson learned from the COVID-19 crisis
Bahareh Yazdizadeh, Reza Majdzadeh, Ayat Ahmadi and Bita Mesgarpour
Health Research Policy and Systems 2020, 18:136 | Published on: 18 December 2020
Strengthening resistance to the COVID-19 pandemic and fostering future resilience requires concerted action on obesity.
Jackson-Morris AM, Nugent R, Ralston J, Barata Cavalcante O, Wilding J.
Glob Health Action. 2020 Dec 31;13(1):1804700. doi: 10.1080/16549716.2020.1804700.
Remote monitoring of marginalised populations affected by COVID-19: a retrospective review.
Ko SQ, Hooi BMY, Koo CY, Chor DWP, Ling ZJ, Chee YL, Jen WY.
BMJ Open. 2020 Dec 31;10(12):e042647. doi: 10.1136/bmjopen-2020-042647.
Telehealth Training During the COVID-19 Pandemic: A Feasibility Study of Large Group Multiplatform Telesimulation Training.
Brei BK, Neches S, Gray MM, Handley S, Castera M, Hedstrom A, D'Cruz R, Kolnik S, Strandjord T, Mietzsch U, Cooper C, Moore JM, Billimoria Z, Sawyer T, Umoren R.
Telemed J E Health. 2020 Dec 30. doi: 10.1089/tmj.2020.0357. Online ahead of print.
Utility of telemedicine in the COVID-19 era.
Colbert GB, Venegas-Vera AV, Lerma EV.
Rev Cardiovasc Med. 2020 Dec 30;21(4):583-587. doi: 10.31083/j.rcm.2020.04.188.
Back to top
08 NSW LATEST NEWS
The National COVID-19 Clinical Evidence Taskforce released new and updated recommendations
and clinical flowcharts
NSW News and media releases
Back to to
09 ACHSM EVENTS
LIVE webcast: Challenges of a Cross Border Health Service
Michael will speak about the challenges of providing health care to the Albury-Wodonga Community including the challenges of the past 12 months with COVID-19.
Date: Friday 29 January 2021
Time: Live at 7.50am (AEDT) to 9.00am
Back to top
_____________________________________________________________________________________
COVID-19 Web Resources
Australia
International
Publication Resources
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Read Past Issues
|
|
|
|